Skip to main content
Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc. — Investor Relations & Filings

Ticker · PCRX ISIN · US6951271005 LEI · 549300P56LERYBDHCF69 US Manufacturing
Open in API
Filings indexed 1,217 across all filing types
Latest filing 2021-02-25 Earnings Release
Country US United States of America
Listing US PCRX

About Pacira BioSciences, Inc.

https://www.pacira.com/

Pacira BioSciences, Inc. is a pharmaceutical company that develops, commercializes, and manufactures non-opioid pain management and regenerative health solutions. The company's mission is to provide alternatives to opioids by delivering innovative, precise, and targeted therapies. Its products and research pipeline address a diverse range of needs, including postsurgical, chronic, and musculoskeletal pain. Pacira is also focused on developing advanced solutions, including gene therapy, to address unmet needs in pain management.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 25, 2021, by Pacira BioSciences, Inc. It specifically states in Item 2.02 that the company issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2020. The document includes the press release as Exhibit 99.1. The text indicates this is an initial announcement of quarterly and annual financial results, which aligns with the definition of an Earnings Release (ER). The document length is 3404 characters, which is relatively short and consistent with a Form 8-K earnings release filing rather than a full detailed report like an Annual Report (10-K) or Interim Report (IR). Therefore, the classification is Earnings Release (ER).
2021-02-25 English
SC 13G/A
Major Shareholding Notification
2021-02-12 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-02-10 English
SCHEDULE 13G/A
Major Shareholding Notification
2021-02-10 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and includes a press release with preliminary unaudited revenue for a recent month. The document does not contain full financial statements or detailed financial analysis, but rather a brief announcement of preliminary financial results. It also states that the press release is furnished as an exhibit and is not deemed "filed" for certain regulatory purposes. The document length is 3388 characters, which is relatively short and consistent with a current report or announcement rather than a full financial report. According to the classification rules, initial announcements of quarterly or periodical financial results (key highlights only) correspond to the Earnings Release (ER) category. Therefore, this document is best classified as an Earnings Release (ER).
2021-02-10 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-02-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.